Cite
GSK343 induces programmed cell death through the inhibition of EZH2 and FBP1 in osteosarcoma cells.
MLA
Xiong, Xifeng, et al. “GSK343 Induces Programmed Cell Death through the Inhibition of EZH2 and FBP1 in Osteosarcoma Cells.” Cancer Biology & Therapy, vol. 21, no. 3, Mar. 2020, pp. 213–22. EBSCOhost, https://doi.org/10.1080/15384047.2019.1680061.
APA
Xiong, X., Zhang, J., Li, A., Dai, L., Qin, S., Wang, P., Liu, W., Zhang, Z., Li, X., & Liu, Z. (2020). GSK343 induces programmed cell death through the inhibition of EZH2 and FBP1 in osteosarcoma cells. Cancer Biology & Therapy, 21(3), 213–222. https://doi.org/10.1080/15384047.2019.1680061
Chicago
Xiong, Xifeng, Jinli Zhang, Aiguo Li, Libing Dai, Shengnan Qin, Pengzhen Wang, Wei Liu, Zhi Zhang, Xiaojian Li, and Zhihe Liu. 2020. “GSK343 Induces Programmed Cell Death through the Inhibition of EZH2 and FBP1 in Osteosarcoma Cells.” Cancer Biology & Therapy 21 (3): 213–22. doi:10.1080/15384047.2019.1680061.